Your browser doesn't support javascript.
loading
Varicella at "Casa Garrahan", 2008-2013: Assessment of postexposure prophylaxis measures.
Ruvinsky, Silvina; Taicz, Moira; Pérez, M Guadalupe; Mónaco, Andrea; García Escudé, Natalia; Inda, Laura; Carbonaro, Mirta; Bologna, Rosa.
Afiliação
  • Ruvinsky S; Servicio de Control Epidemiológico e Infectología, Hospital de Pediatría Prof. Dr. Juan P. Garrahan.
  • Taicz M; Servicio de Control Epidemiológico e Infectología, Hospital de Pediatría Prof. Dr. Juan P. Garrahan.
  • Pérez MG; Servicio de Control Epidemiológico e Infectología, Hospital de Pediatría Prof. Dr. Juan P. Garrahan.
  • Mónaco A; Servicio de Control Epidemiológico e Infectología, Hospital de Pediatría Prof. Dr. Juan P. Garrahan.
  • García Escudé N; Servicio de Control Epidemiológico e Infectología, Hospital de Pediatría Prof. Dr. Juan P. Garrahan.
  • Inda L; Servicio de Control Epidemiológico e Infectología, Hospital de Pediatría Prof. Dr. Juan P. Garrahan.
  • Carbonaro M; Servicio de Control Epidemiológico e Infectología, Hospital de Pediatría Prof. Dr. Juan P. Garrahan.
  • Bologna R; Servicio de Control Epidemiológico e Infectología, Hospital de Pediatría Prof. Dr. Juan P. Garrahan.
Arch Argent Pediatr ; 113(3): 237-43, 2015 06.
Article em En, Es | MEDLINE | ID: mdl-25996322
ABSTRACT

INTRODUCTION:

Casa Garrahan (CG) accommodates children with complex conditions referred nationwide; these children are seen in children's hospitals located in the Autonomous City of Buenos Aires. Varicella is a highly-contagious disease, with attack rates of up to 90% among susceptible individuals. In closed communities, the implementation of outbreak control measures is critical.

OBJECTIVES:

To describe the characteristics of children exposed to varicella at CG, the implemented prophylaxis measures and their effectiveness.

METHODS:

Prospective, cohort study. Children exposed to varicella at CG between2008 and 2013, their demographic and clinical characteristics, immunization and/or history of varicella, prophylaxis measures, and secondary attack rate were assessed.

RESULTS:

N 107. Fifty-three percent (n 57) were girls. Their median age was 84 months old [interquartile range (IQR) 24-144]. Ninety-five percent (n 102) had an underlying disease [hemato-oncological disease 39% (n 42); neurological disease 18% (n 19); congenital heart disease 9% (n 10); and post-operative period 65 (n 6)]. Fifty percent had some degree of immunosuppression (n 54). Twenty-nine percent (n 31) referred to have had varicella; 27% (n 29) indicated that they never had the infection; and 41% (n 44) did not recall a history of varicella. Only 3% (n 3) had been vaccinated. Based on their immune status, age and history of varicella, acyclovir was indicated as prophylaxis in 61% (n 65); immunization in 10% (n 10); and gamma globulin in 1 patient. No adverse effects were observed in relation to the different prophylaxis measures. No secondary cases were observed at 30 days.

CONCLUSIONS:

Implemented measures were effective to prevent secondary cases. Among healthy and immunocompromised children, prophylaxis with acyclovir was effective and well-tolerated.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Aciclovir / Varicela / Vacina contra Varicela / Profilaxia Pós-Exposição Idioma: En / Es Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Aciclovir / Varicela / Vacina contra Varicela / Profilaxia Pós-Exposição Idioma: En / Es Ano de publicação: 2015 Tipo de documento: Article